Navigation Links
Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series
Date:5/22/2012

AUSTIN, Texas, May 22, 2012 /PRNewswire/ -- SmallCapVoice.com, Inc. announced today that a new audio interview with Medical Marijuana, Inc. (PINKSHEETS: MJNA) is now available. The interview can be heard at http://smallcapvoice.com/blog/5-21-12-smallcapvoice-interview-with-medical-marijuana-inc-pink-sheets-mjna.

Recent company activity and highlights:

The company earned net income of approximately $1.21 million on gross revenues of $1.79 million for the quarter ended March 31, 2012.  This represents a gross revenue increase of 400 plus percent quarter-over-quarter when compared to revenue of $430,000 for the quarter ended December 31, 2011 and an accumulative 12,000 plus percent increase in revenue since the same quarter last year. Operating expenses were approximately $580,000 for the quarter.

Operational and development highlightsOperating highlights of the quarter were as follows:

  • Acquired two additional Wellness Managed Services accounts which will generate estimated annual revenues of $1.7 million.
  • Closed a $1.04 million upfront payment licensing transaction for high value hemp extracts.
  • Retired 14,600,000 shares worth approximately $1.0 million dollars.
  • Cannabank, the private equity group that finances and incubates early stage acquisitions for MJNA, has agreed to finance several key transactions for the company including the European based pharmaceutical firm previously announced.
  • Secured $4 million in non-dilution, non-recourse finance for the acquisition and development of strategic acquisitions. 
  • In addition, since the close of the first quarter, Medical Marijuana, Inc. has:

  • Completed the acquisition of Dixie Elixirs & Edibles brand, intellectual property, proprietary formulas and extraction processes. In conjunction it formed Red Dice Holdings, as was announced in late April, to develop manufacturing and distribution partnerships for Dixie in every state and country that has legalized medical cannabis.
  • Begun hemp-based extraction product development beyond the medical marijuana industry, crossing into the nationally legal category of health and wellness with such products as sleep aids, topical and pain management. A market launch of the new products is expected by the end of the second quarter.
  • Brought PhytoSPHERE systems on-line and will begin to market the benefits of its seed-to-sale product growth and cultivation technology in an attempt to secure licensing agreements worldwide.
  • Additional operational updates for 2012

  • The Company has built additional raw ingredients supply sources on four continents in preparation for international expansion and it continues to develop international sales and distribution channels for its high-value extracts and compounds and related products produced by Dixie Elixirs and Edibles.
  • Medical Marijuana, Inc.'s Wellness Managed Services (WMS) division plans to expand internationally to provide additional clinics, doctor's offices and wellness centers under the WMS umbrella.
  • PhytoSPHERE plans to develop and launch a national/international marketing campaign in the third quarter to support sales of licensing agreements for its proprietary indoor planting, cultivation and extraction technology.
  • Medical Marijuana, Inc. plans to establish a "Raw Ingredients Division" by the third quarter to provide raw ingredients and production services to other cannabis-based businesses.
  • MJNA to begin regular Investor Conference Calls announcing quarterly results and/or upon significant corporate developments beginning with its second quarter results (date is currently TBD).
  • MJNA established a corporate website and launched a rebranding effort for added market and shareholder awareness.
  • The Company is aggressively pursuing the acquisition and filing of additional product patents. 
  • MJNA Filed an updated 15-C-211
  •  Quarterly Three months endedMar. 31, 2011Three months endedJun. 30, 2011Three months endedSept. 30, 2011Three months endedDec. 31, 2011Three months endedMar. 31, 2012Revenue$20,426

    $196,748

    $198,813

    $430,140

    $1,788,445Assets$74,376

    $568,116

    $1,443,251

    $1,948,165

    $6,356,301Debt$73,403

    $103,464

    $14,879

    $26,785

    $101,778Net Income($42,613)

    ($1,292,722)

    ($1,067,473)

    ($62,711)

    $1,208,136About SmallCapVoice.comSmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

    About Medical Marijuana, Inc.Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit.  We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.  For more information, please visit the company's website at: www.MedicalMarijuanaInc.com.

    FORWARD-LOOKING DISCLAIMER

    This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections.  This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

    Corporate Contact:
    Medical Marijuana, Inc.
    Toll Free:  888-OTC-MJNA (888-682-6562)
    www.medicalmarijuanainc.com
    www.facebook.com/mjnainc

    Investor Relations Contact:
    Stuart T. Smith
    SmallCapVoice.Com, Inc.
    P. 512-267-2430
    F. 512-267-2530
    Skype: SmallCapVoice.com
    AIM: SmallCapVoice7 


    '/>"/>

    SOURCE SmallCapVoice.com
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial
    2. Gentech Pharmaceutical Appoints New Medical Director for PhenTabz/ADDTabz
    3. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
    4. Elevate Provides Remote Access to Personal Health Records Using MyMedicalRecords.com
    5. Dangerous Medical Device Loophole Puts Patients At Risk
    6. Medical Device Developers - Network at MD&M East Next Week
    7. Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients
    8. Richard Wolf Medical Instruments introduces groundbreaking 5514 Endocam Performance HD
    9. Dehaier Medical to Present at the CFA 2012 Cross-Continental Summit on Investment in Shanghai
    10. Tegra Medical Announces New President/CEO
    11. Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
    (Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
    (Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
    Breaking Medicine Technology:
    (Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
    (Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
    (Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
    (Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
    (Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
    Breaking Medicine News(10 mins):